Javascript must be enabled to continue!
How Can We Promote COVID-19 Vaccination? - Comparison of the Potential Influence between Opt-out and Opt-in Defaults
View through CrossRef
Vaccination is the key infection control measure against Coronavirus Disease 2019 (COVID-19). Most municipalities in Japan have adopted an opt-in system for COVID-19 vaccination, but its background information is limited. We, therefore, aimed to examine the differences in vaccination coverages and their cancellation rates between opt-in and opt-out settings for COVID-19 vaccination in 10 cities in A prefecture, Japan. 10 cities in A Prefecture were surveyed by email as of 10 October 2021 on the vaccination coverage by age group (12 years and older) and the cancellation rate on the day of vaccination. We also checked on the complaints received in the opt-out group. Opt-out was adopted in one of the ten cities in which vaccination was designed for all household members aged 15-64, thus serving as the opt-out group. Vaccination coverage in the opt-out group was 88.2%-89.2% for the first dose and 84.9%-86.0% for the second dose at 95% confidence intervals in the comparable 20–64-year age group. In contrast, the overall opt-in group (nine cities, one of which did not have an identified vaccination rate) was 51.3%-83.6% for the first dose and 63.5%-74.8% for the second dose in the same age group. For the opt-out group, the cancellation rate on the day was 11.3% for the first dose and 3.7% for the second dose, which had a lower cancellation rate than that of the opt-out on influenza vaccines in previous studies, 71%. Meanwhile, the opt-in group did not monitor them. There were no complaints about default changes in the opt-out group. While there is room for further research, such as understanding the reasons for accepting the default change by residents in the opt-out group, it was suggested that making opt-out the default would promote COVID-19 vaccination.
Title: How Can We Promote COVID-19 Vaccination? - Comparison of the Potential Influence between Opt-out and Opt-in Defaults
Description:
Vaccination is the key infection control measure against Coronavirus Disease 2019 (COVID-19).
Most municipalities in Japan have adopted an opt-in system for COVID-19 vaccination, but its background information is limited.
We, therefore, aimed to examine the differences in vaccination coverages and their cancellation rates between opt-in and opt-out settings for COVID-19 vaccination in 10 cities in A prefecture, Japan.
10 cities in A Prefecture were surveyed by email as of 10 October 2021 on the vaccination coverage by age group (12 years and older) and the cancellation rate on the day of vaccination.
We also checked on the complaints received in the opt-out group.
Opt-out was adopted in one of the ten cities in which vaccination was designed for all household members aged 15-64, thus serving as the opt-out group.
Vaccination coverage in the opt-out group was 88.
2%-89.
2% for the first dose and 84.
9%-86.
0% for the second dose at 95% confidence intervals in the comparable 20–64-year age group.
In contrast, the overall opt-in group (nine cities, one of which did not have an identified vaccination rate) was 51.
3%-83.
6% for the first dose and 63.
5%-74.
8% for the second dose in the same age group.
For the opt-out group, the cancellation rate on the day was 11.
3% for the first dose and 3.
7% for the second dose, which had a lower cancellation rate than that of the opt-out on influenza vaccines in previous studies, 71%.
Meanwhile, the opt-in group did not monitor them.
There were no complaints about default changes in the opt-out group.
While there is room for further research, such as understanding the reasons for accepting the default change by residents in the opt-out group, it was suggested that making opt-out the default would promote COVID-19 vaccination.
Related Results
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
Abstract
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vaccination coverage. Our results confirm that vaccines ar...
How can we promote vaccination of the mass population?—Lessons from the COVID-19 vaccination defaults
How can we promote vaccination of the mass population?—Lessons from the COVID-19 vaccination defaults
While vaccines are pivotal in combating COVID-19, concerns about side effects and complex procedures have hindered complete vaccination. Prior studies suggest that individuals defa...
PERSEPSI IBU HAMIL TENTANG VAKSIN COVID-19 TERHADAP PELAKSANAAN VAKSINASI COVID-19
PERSEPSI IBU HAMIL TENTANG VAKSIN COVID-19 TERHADAP PELAKSANAAN VAKSINASI COVID-19
Latar Belakang: kasus positif Covid-19 di Kabupaten Sukoharjo tahun 2021 mencapai 12.350 dan terus mengalami penambahan jumlah. Dari jumlah tersebut terdapat 168 kasus positif Covi...
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID is the consequence of having had COVID. Long COVID has many other names including Long-haul COVID, Post-COVID conditions (PCC), Post-COVID-19 syndrome, Post-acute seque...
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID is the consequence of having had COVID. Long COVID has many other names including Long-haul COVID, Post-COVID conditions (PCC), Post-COVID-19 syndrome, Post-acute seque...
Estimating Vaccine-Preventable COVID-19 Deaths Under Counterfactual Vaccination Scenarios in the United States
Estimating Vaccine-Preventable COVID-19 Deaths Under Counterfactual Vaccination Scenarios in the United States
Abstract
Importance
With an abundant supply of COVID-19 vaccines becoming available in spring and summer 2021, the major barrie...

